GILLIAN REED: Open Payments
NPI 1568198778 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 18 payments from 17 companies in 2025. Trend: 2023 $427 · 2024 $334 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $50 |
| Legend Biotech USA Inc. | 1 | $34 |
| Karyopharm Therapeutics Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $28 |
| GENZYME CORPORATION | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| SOBI, INC | 1 | $21 |
| Celgene Corporation | 1 | $21 |
Products named: CARVYKTI, XPOVIO, Vyloy, SARCLISA, MONJUVI, NINLARO, JAKAFI, POTELIGEO.
Industry payments across TN — which companies pay providers there.
